Exacerbated corneal inflammation and neovascularization in the HO-2 null mice is ameliorated by biliverdin

Experimental Eye Research

Volumn 87, Issue 3, 2008, Pages 268-278

  Bellner, Lars ^a   Vitto, Marco ^a   Patil, Kiran A ^a   Dunn, Michael W ^a   Regan, Raymond ^b   Laniado Schwartzman, Michal ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

biliverdin; hemangiogenesis; heme oxygenase; inflammation; lymphangiogenesis

Indexed keywords

BILIVERDIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; CORNEA PERFORATION; CORNEA ULCER; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOFLUORESCENCE; KERATITIS; LEUKOCYTE; LYMPHANGIOGENESIS; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STAINING;

ANIMALS; BILIVERDINE; CORNEA; CORNEAL NEOVASCULARIZATION; DISEASE PROGRESSION; DRUG EVALUATION, PRECLINICAL; FEMALE; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; KERATITIS; MALE; MICE; MICE, KNOCKOUT; PEROXIDASE;

EID: 50849094843     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2008.06.007     Document Type: Article

References (60)

1. Abraham N.G., da Silva J.L., Lavrovsky Y., Stoltz R.A., Kappas A., Dunn M.W., and Schwartzman M.L. Adenovirus-mediated heme oxygenase-1 gene transfer into rabbit ocular tissues. Invest. Ophthalmol. Vis. Sci. 36 (1995) 2202-2010
2. Abraham N.G., and Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol. Rev. 60 (2008) 79-127
3. Abraham N.G., Lin J., Dunn M.W., and Schwartzman M.L. Presence of heme oxygensae and NADPH cytochrome P450 (c) reductase in human corneal epithelium. Invest. Ophthalmol. Vis. Sci. 28 (1987) 1464-1472
4. Arai-Gaun S., Katai N., Kikuchi T., Kurokawa T., Ohta K., and Yoshimura N. Heme oxygenase-1 induced in Muller cells plays a protective role in retinal ischemia-reperfusion injury in rats. Invest. Ophthalmol. Vis. Sci. 45 (2004) 4226-4232
5. Basuroy S., Bhattacharya S., Tcheranova D., Qu Y., Regan R.F., Leffler C.W., and Parfenova H. HO-2 provides endogenous protection against oxidative stress and apoptosis caused by TNF-alpha in cerebral vascular endothelial cells. Am. J. Physiol. Cell Physiol. 291 (2006) C897-C908
6. Boehning D., Moon C., Sharma S., Hurt K.J., Hester L.D., Ronnett G.V., Shugar D., and Snyder S.H. Carbon monoxide neurotransmission activated by CK2 phosphorylation of heme oxygenase-2. Neuron 40 (2003) 129-137
7. Bonazzi A., Mastyugin V., Mieyal P.A., Dunn M.W., and Laniado Schwartzman M. Regulation of cyclooxygenase-2 by hypoxia and PPAR ligands in the rabbit corneal epithelium. J. Biol. Chem. 275 (2000) 2837-2844
8. Chang E.F., Wong R.J., Vreman H.J., Igarashi T., Galo E., Sharp F.R., Stevenson D.K., and Noble-Haeusslein L.J. Heme oxygenase-2 protects against lipid peroxidation-mediated cell loss and impaired motor recovery after traumatic brain injury. J. Neurosci. 23 (2003) 3689-3696
9. Coito A.J., Buelow R., Shen X.D., Amersi F., Moore C., Volk H.D., Busuttil R.W., and Kupiec-Weglinski J.W. Heme oxygenase-1 gene transfer inhibits inducible nitric oxide synthase expression and protects genetically fat Zucker rat livers from ischemia-reperfusion injury. Transplantation 74 (2002) 96-102
10. Conners M.S., Stoltz R.A., Dunn M.W., Levere R.D., Abraham N.G., and Schwartzman M.L. A closed eye-contact lens model of corneal inflammation. II. Inhibition of cytochrome P450 arachidonic acid metabolism alleviates inflammatory sequelae. Invest. Ophthalmol. Vis. Sci. 36 (1995) 841-850
11. Cursiefen C., Chen L., Borges L.P., Jackson D., Cao J., Radziejewski C., D'Amore P.A., Dana M.R., Wiegand S.J., and Streilein J.W. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J. Clin. Invest 113 (2004) 1040-1050
12. Cursiefen C., Maruyama K., Jackson D.G., Streilein J.W., and Kruse F.E. Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation. Cornea 25 (2006) 443-447
13. Dennery P.A., Spitz D.R., Yang G., Tatarov A., Lee C.S., Shegog M.L., and Poss K.D. Oxygen toxicity and iron accumulation in the lungs of mice lacking heme oxygenase-2. J. Clin. Invest 101 (1998) 1001-1011
14. Ding Y., Zhang Y.Z., Furuyama K., Ogawa K., Igarashi K., and Shibahara S. Down-regulation of heme oxygenase-2 is associated with the increased expression of heme oxygenase-1 in human cell lines. FEBS J. 273 (2006) 5333-5346
15. Dore S., Sampei K., Goto S., Alkayed N.J., Guastella D., Blackshaw S., Gallagher M., Traystman R.J., Hurn P.D., Koehler R.C., and Snyder S.H. Heme oxygenase-2 is neuroprotective in cerebral ischemia. Mol. Med. 5 (1999) 656-663
16. Dore S., Takahashi M., Ferris C.D., Zakhary R., Hester L.D., Guastella D., and Snyder S.H. Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 2445-2450
17. Fondevila C., Shen X.D., Tsuchiyashi S., Yamashita K., Csizmadia E., Lassman C., Busuttil R.W., Kupiec-Weglinski J.W., and Bach F.H. Biliverdin therapy protects rat livers from ischemia and reperfusion injury. Hepatology 40 (2004) 1333-1341
18. Foresti R., Green C.J., and Motterlini R. Generation of bile pigments by haem oxygenase: a refined cellular strategy in response to stressful insults. Biochem. Soc. Symp. (2004) 177-192
19. Gibbs P.E., and Maines M.D. Biliverdin inhibits activation of NF-kappaB: reversal of inhibition by human biliverdin reductase. Int. J. Cancer 121 (2007) 2567-2574
20. Haider A., Olszanecki R., Gryglewski R., Schwartzman M.L., Lianos E., Kappas A., Nasjletti A., and Abraham N.G. Regulation of cyclooxygenase by the heme-heme oxygenase system in microvessel endothelial cells. J. Pharmacol. Exp. Ther. 300 (2002) 188-194
21. Hegazy K.A., Dunn M.W., and Sharma S.C. Functional human heme oxygenase has a neuroprotective effect on adult rat ganglion cells after pressure-induced ischemia. Neuroreport 11 (2000) 1185-1189
22. Kapturczak M.H., Wasserfall C., Brusko T., Campbell-Thompson M., Ellis T.M., Atkinson M.A., and Agarwal A. Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. Am. J. Pathol. 165 (2004) 1045-1053
23. Kim Y.S., and Dore S. Catalytically inactive heme oxygenase-2 mutant is cytoprotective. Free Radic. Biol. Med. 39 (2005) 558-564
24. Kim Y.S., Zhuang H., Koehler R.C., and Dore S. Distinct protective mechanisms of HO-1 and HO-2 against hydroperoxide-induced cytotoxicity. Free Radic. Biol. Med. 38 (2005) 85-92
25. Laniado Schwartzman M., Abraham N.G., Conners M.S., Dunn M.W., Levere R.D., and Kappas A. Heme oxygenase induction with attenuation of experimentally-induced corneal inflammation. Biochem. Pharmacol. 53 (1997) 1069-1075
26. Li Volti G., Sacerdoti D., Sangras B., Vanella A., Mezentsev A., Scapagnini G., Falck J.R., and Abraham N.G. Carbon monoxide signaling in promoting angiogenesis in human microvessel endothelial cells. Antioxid. Redox. Signal. 7 (2005) 704-710
27. Li Volti G., Seta F., Schwartzman M.L., Nasjletti A., and Abraham N.G. Heme oxygenase attenuates angiotensin II-mediated increase in cyclooxygenase-2 activity in human femoral endothelial cells. Hypertension 41 (2003) 715-719
28. Maines M.D. Heme oxygenase: function, multiplicity, regulatory mechanisms and clinical applications. FASEB J. 2 (1998) 2557-2568
29. Maruyama K., Ii M., Cursiefen C., Jackson D.G., Keino H., Tomita M., Van Rooijen N., Takenaka H., D'Amore P.A., Stein-Streilein J., Losordo D.W., and Streilein J.W. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J. Clin. Invest. 115 (2005) 2363-2372
30. McCoubrey Jr. W.K., Huang T.J., and Maines M.D. Heme oxygenase-2 is a hemoprotein and binds heme through heme regulatory motifs that are not involved in heme catalysis. J. Biol. Chem. 272 (1997) 12568-12574
31. Minamino T., Christou H., Hsieh C.M., Liu Y., Dhawan V., Abraham N.G., Perrella M.A., Mitsialis S.A., and Kourembanas S. Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 8798-8803
32. Morse D., Pischke S.E., Zhou Z., Davis R.J., Flavell R.A., Loop T., Otterbein S.L., Otterbein L.E., and Choi A.M. Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J. Biol. Chem. 278 (2003) 36993-36998
33. Nakao A., Otterbein L.E., Overhaus M., Sarady J.K., Tsung A., Kimizuka K., Nalesnik M.A., Kaizu T., Uchiyama T., Liu F., Murase N., Bauer A.J., and Bach F.H. Biliverdin protects the functional integrity of a transplanted syngeneic small bowel. Gastroenterology 127 (2004) 595-606
34. Neil T.K., Stoltz R.A., Jiang S., Laniado-Schwartzman M., Dunn M.W., Levere R.D., Kappas A., and Abraham N.G. Modulation of corneal heme oxygenase expression by oxidative stress agents. J. Ocul. Pharmacol. Ther. 11 (1995) 455-468
35. Ohta K., Kikuchi T., Arai S., Yoshida N., Sato A., and Yoshimura N. Protective role of heme oxygenase-1 against endotoxin-induced uveitis in rats. Exp. Eye Res. 77 (2003) 665-673
36. Ollinger R., Wang H., Yamashita K., Wegiel B., Thomas M., Margreiter R., and Bach F.H. Therapeutic applications of bilirubin and biliverdin in transplantation. Antioxid. Redox. Signal 9 (2007) 2175-2185
37. Otterbein L.E. Carbon monoxide: innovative anti-inflammatory properties of an age-old gas molecule. Antioxid. Redox. Signal 4 (2002) 309-319
38. Otterbein L.E., Bach F.H., Alam J., Soares M., Tao Lu H., Wysk M., Davis R.J., Flavell R.A., and Choi A.M. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 6 (2000) 422-428
39. Otterbein L.E., and Choi A.M. Heme oxygenase: colors of defense against cellular stress. Am. J. Physiol. Lung Cell. Mol. Physiol. 279 (2000) L1029-L1037
40. Parfenova H., Basuroy S., Bhattacharya S., Tcheranova D., Qu Y., Regan R.F., and Leffler C.W. Glutamate induces oxidative stress and apoptosis in cerebral vascular endothelial cells: contributions of HO-1 and HO-2 to cytoprotection. Am. J. Physiol. Cell Physiol. 290 (2006) C1399-C1410
41. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29 (2001) 2002-2007
42. Poss K.D., Thomas M.J., Ebralidze A.K., O'Dell T.J., and Tonegawa S. Hippocampal long-term potentiation is normal in heme oxygenase-2 mutant mice. Neuron 15 (1995) 867-873
43. Poss K.D., and Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 10919-10924
44. Rogers B., Yakopson V., Teng Z.P., Guo Y., and Regan R.F. Heme oxygenase-2 knockout neurons are less vulnerable to hemoglobin toxicity. Free Radic. Biol. Med. 35 (2003) 872-881
45. Ryter S.W., Morse D., and Choi A.M. Carbon monoxide: to boldly go where NO has gone before. Sci. STKE 2004 (2004) RE6
46. Ryter S.W., and Otterbein L.E. Carbon monoxide in biology and medicine. Bioessays 26 (2004) 270-280
47. Samolov B., Steen B., Seregard S., van der Ploeg I., Montan P., and Kvanta A. Delayed inflammation-associated corneal neovascularization in MMP-2-deficient mice. Exp. Eye Res. 80 (2005) 159-166
48. Sarady-Andrews J., Liu F., Gallo D., Nakao A., Overhaus M., Ollinger R., Choi A.M., and Otterbein L.E. Biliverdin administration protects against endotoxin-induced acute lung injury in rats. Am. J. Physiol. Lung Cell. Mol. Physiol. 289 (2005) L1131-L1137
49. Seta F., Bellner L., Rezzani R., Regan R.F., Dunn M.W., Abraham N.G., Gronert K., and Laniado-Schwartzman M. Heme oxygenase-2 is a critical determinant for execution of an acute inflammatory and reparative response. Am. J. Pathol. 169 (2006) 1612-1623
50. Shibahara S. The heme oxygenase dilemma in cellular homeostasis: new insights for the feedback regulation of heme catabolism. Tohoku J. Exp. Med. 200 (2003) 167-186
51. Song R., Kubo M., Morse D., Zhou Z., Zhang X., Dauber J.H., Fabisiak J., Alber S.M., Watkins S.C., Zuckerbraun B.S., Otterbein L.E., Ning W., Oury T.D., Lee P.J., McCurry K.R., and Choi A.M. Carbon monoxide induces cytoprotection in rat orthotopic lung transplantation via anti-inflammatory and anti-apoptotic effects. Am. J. Pathol. 163 (2003) 231-242
52. Stocker R., Yamamoto Y., McDonagh A.F., Glazer A.N., and Ames B.N. Bilirubin is an antioxidant of possible physiological importance. Science 235 (1987) 1043-1046
53. Wagener F.A., da Silva J.L., Farley T., de Witte T., Kappas A., and Abraham N.G. Differential effects of heme oxygenase isoforms on heme mediation of endothelial intracellular adhesion molecule 1 expression. J. Pharmacol. Exp. Ther. 291 (1999) 416-423
54. Wagener F.A., Volk H.D., Willis D., Abraham N.G., Soares M.P., Adema G.J., and Figdor C.G. Different faces of the heme-heme oxygenase system in inflammation. Pharmacol. Rev. 55 (2003) 551-571
55. Willis D., Moore A.R., Frederick R., and Willoughby D.A. Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat. Med. 2 (1996) 87-90
56. Yachie A., Niida Y., Wada T., Igarashi N., Kaneda H., Toma T., Ohta K., Kasahara Y., and Koizumi S. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J. Clin. Invest 103 (1999) 129-135
57. Yamashita K., McDaid J., Ollinger R., Tsui T.Y., Berberat P.O., Usheva A., Csizmadia E., Smith R.N., Soares M.P., and Bach F.H. Biliverdin, a natural product of heme catabolism, induces tolerance to cardiac allografts. FASEB J. 18 (2004) 765-767
58. Yet S.F., Tian R., Layne M.D., Wang Z.Y., Maemura K., Solovyeva M., Ith B., Melo L.G., Zhang L., Ingwall J.S., Dzau V.J., Lee M.E., and Perrella M.A. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ. Res. 89 (2001) 168-173
59. Zakhary R., Poss K.D., Jaffrey S.R., Ferris C.D., Tonegawa S., and Snyder S.H. Targeted gene deletion of heme oxygenase 2 reveals neural role for carbon monoxide. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 14848-14853
60. Zampetaki A., Minamino T., Mitsialis S.A., and Kourembanas S. Effect of heme oxygenase-1 overexpression in two models of lung inflammation. Exp. Biol. Med. (Maywood) 228 (2003) 442-446